Paasa Logo
Rhythm Pharmaceuticals, Inc. logo
RYTMNASDAQMarket closedOpens 9:30am ET

Rhythm Pharmaceuticals, Inc.

$95.71Last updated
-$2.85 (2.89%)Past day
Timezone

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is trading at $95.71, about ₹9,194 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 2.89% today. Indian residents can buy Rhythm Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$97.92
Previous close:$98.56
Volume:810.80K

Today's low

$94.51

Today's high

$98.91

52 week low

$74.50

52 week high

$122.20

RYTM opened at $97.92, closed previously at $98.56, and has traded between $74.50 and $122.20 over the past 52 weeks.

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or the leptin receptor (LEPR), alongside its use in patients with Bardet-Biedl and Alström syndromes. Furthermore, the company is progressing setmelanotide (the active compound in IMCIVREE) through Phase II clinical trials. These studies are evaluating its potential for a broader spectrum of applications, including obesity caused by heterozygous POMC or LEPR deficiencies, steroid receptor coactivator 1 (SRC1) deficiency, SH2B1 deficiency, MC4 receptor deficiency, and obesity associated with Smith-Magenis syndrome, POMC epigenetic disorders, and other MC4R-related conditions. Rhythm Pharmaceuticals holds a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The firm, headquartered in Boston, Massachusetts, was established in 2008 and changed its name from Rhythm Metabolic, Inc. to Rhythm Pharmaceuticals, Inc. in October 2015.

Country
US
CEO
David Meeker
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
414
Sector
Healthcare
IPO date
09/10/2017

Key statistics

Avg. volume

715.48K

Market cap

$6.57B

P/E Ratio

-30.77

Price-to-sales ratio

27.36

Enterprise value

$6.91B

Free cash flow yield

-1.68%

Debt-to-equity ratio

0.02

Return on equity

-72.79%

ROIC

-51.22%

Beta

1.97

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$189.76M

Earnings per share

-$3.11

Free cash flow

-$116.63M

Net profit margin

-85.59%

Gross margin

89.00%

EBITDA

-$174.12M

Revenue growth

45.83%

Similar securities

This is not an investment recommendation

How to buy Rhythm Pharmaceuticals from India

Indian residents can buy Rhythm Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Rhythm Pharmaceuticals and place an order

    Find Rhythm Pharmaceuticals by name or by its ticker, RYTM, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Rhythm Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Rhythm Pharmaceuticals position in USD and INR. Rhythm Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Rhythm Pharmaceuticals from India

Trading and taxes when buying Rhythm Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneRhythm Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Rhythm Pharmaceuticals stock?

Yes. Rhythm Pharmaceuticals (RYTM) has been listed on NASDAQ since 2017, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Rhythm Pharmaceuticals share cost in rupees?

One Rhythm Pharmaceuticals share is $95.71 — about ₹9,194 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Rhythm Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Rhythm Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Rhythm Pharmaceuticals?

Yes. One Rhythm Pharmaceuticals share is $95.71, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Rhythm Pharmaceuticals.

How are gains on Rhythm Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Rhythm Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Rhythm Pharmaceuticals pay a dividend?

No. Rhythm Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Rhythm Pharmaceuticals from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Rhythm Pharmaceuticals shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Rhythm Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Rhythm Pharmaceuticals holding, its cost and its closing value.

How do I sell Rhythm Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.